Protagonist Therapeutics Stock (NASDAQ:PTGX), Quotes and News Summary

Q: What sector and industry does Protagonist Therapeutics (PTGX) operate in?

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 685.798K
Day Range	- - -
52 Wk Range	13.720 - 33.340
Market Cap	$1.490B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	5.97%
Days to Cover	7.2

Recent News

Why Is Japanese Drugmaker Takeda Stock Trading Lower Today?

Takeda Pharmaceutical's Q3 2023 results: ¥235.9 billion core net profit, management changes, and a global collaboration deal for rusfertide. Fiscal year 2023 guidance reiterated.

Vandana Singh

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Lisa Levin

Analyst Boosts Protagonist Therapeutics Price Target, Says Psoriasis Data Impressive

JMP Securities has increased the price target for Protagonist Therapeutics Inc (NASDAQ: PTGX) from $28 to $35,

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Oct 23

Nov 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Protagonist Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Protagonist Therapeutics (PTGX) stock?

You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.

View our list of the best stock brokerages.

Who are Protagonist Therapeutics's (PTGX) competitors?

Other companies in Protagonist Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT) and Syndax Pharmaceuticals (NASDAQ:SNDX).

What is the target price for Protagonist Therapeutics (PTGX) stock?

The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by HC Wainwright & Co. on Monday, March 11, 2024. The analyst firm set a price target for 38.00 expecting PTGX to rise to within 12 months (a possible 48.61% upside). 15 analyst firms have reported ratings in the last year.

Current Stock Price for Protagonist Therapeutics (PTGX)?

The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $25.57 last updated April 17, 2024 at 4:20 PM EDT.

Does Protagonist Therapeutics (PTGX) pay a dividend?

There are no upcoming dividends for Protagonist Therapeutics.

When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?

Protagonist Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Protagonist Therapeutics (PTGX) going to split?

There is no upcoming split for Protagonist Therapeutics.

What sector and industry does Protagonist Therapeutics (PTGX) operate in?

Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-